Market Synopsis
Competitive Market Growth, Size, Share and Forecast to 2030 for Pet Cancer Therapeutics Market 2019 2027, By Animal Type (Dogs, Cats, Horses, Others); By Cancer Type (Mast Cell Cancer, Lymphoma, Melanoma, Mammary, Squamous Cell Cancer, Others);
Market Snapshot
The Pet Cancer Therapeutics Market 2019 2027 was valued US$ 601.43 million in 2021 and will grow at a CAGR of 11.20% for the forecast period of 2014-2030, as per the market research report by Absolute Markets Insights titled ” Pet Cancer Therapeutics Market 2019 2027
Read Full Research Report @
Report Description Pet Cancer Therapeutics Market 2019 2027.
Market Overview
Rising prevalence of cancer among the cats and dogs is expected to propel the overall industry growth. The Veterinary Cancer Society reported that cancer is the leading cause of death for 47.5% of the dogs who are aged over ten and 32% of the cats. The most common cancer type among the dogs are different forms of lymphoma, showing enlargement of external lymph nodes. Early detection and adequate treatment are the best way to manage cancer in pets. Most prevalent types of cancer occurs in skin, mammary gland, head & neck, testicles, abdominal cancer and bone. Cancer treatment types include surgery, chemotherapy, stereotactic radiation, conventional radiation therapy, palliative care, immunotherapy, cryotherapy and radioactive iodine I-131. Increasing investment for research and development for new diagnostic methods and treatments for cancer management will drive the growth of pet cancer therapeutics market.
Pharmaceutical companies investing in veterinary medicine have introduced a robust pipeline of drug for the treatment of highly prevalent conditions in pets such as lymphoma and melanoma. In January 2018, Aratana Therapeutics announced approval of its canine osteosarcoma vaccine, Live Listeria Vector (AT-014), from United States Department of Agriculture (USDA) Center. Private and government organizations such as Veterinary Cancer Society, Petco Foundation and Animal Cancer foundation are also working together with pharmaceutical companies to formulate novel drug for pet cancer therapeutics which will positively impact the industry growth.
Spotlight Innovation, Inc., announced that it has formed a subsidiary named, CDT Veterinary Therapeutics, Inc., to develop cancer therapeutics for the veterinary market. The company is a third subsidiary of Spotlight Innovation’s along with Memcine Pharmaceuticals and Celtic Biotech. The company commercialized the production of Crotalin which is considered an effective cancer therapeutic in companion animals. According to the American Veterinary Medical Association (AAPA), veterinary care costs were approximately US$15.04 billion in the United States for the year 2014. Due to increasing costs, the North American Pet Health Insurance Association duly reported the increased companion animal healthcare insurance policies since 2009. Increasing number of such policies since then and addition of the same in the year 2013, has estimated the North America market size to be US$ 601.43 million in in 2014.
The term Pet Cancer Therapeutics Market 2019 2027 is determined by a number of variables, including forward/backward integration, economies of scale, the proportion of different distribution channels, variables influencing consumer behavior, such as brand loyalty, price, and accessibility of the product, capital investments, the regulatory environment, production rights and patents, marketing strategies, and other client preferences. The stakeholders in the industry will most likely find this knowledge useful, and it might even motivate them to act.
Get Access to a Free Copy of Our Latest Sample Report @
Sample Pages Pet Cancer Therapeutics Market 2019 2027 .
Pet Cancer Therapeutics Market 2019 2027 Competitive Landscape:
The prominent companies in the Pet Cancer Therapeutics Market 2019 2027 are:
include AdvaVet, Advaxis Inc., Amgen Inc., Aratana Therapeutics, Inc., Boehringer Ingelheim International GmbH, CanFel Therapeutics, ELIAS Animal Health, Fetch Pharma, Genentech, Innogenics, Karyopharm Therapeutics, Kindred Biosciences, Morphogenesis, Inc., NIPPON ZENYAKU KOGYO CO., LTD., Oasmia Pharmaceutical AB, PetLife Pharmaceuticals, Inc., Pharmaust., Phibro Animal Health Corporation, Regeneus Ltd, Rhizen Pharmaceuticals S.A., Torigen Pharmaceutical Inc., Vaccibody, VetDC, Virbac., Zoetis Services LLC amongst others.
Impact of COVID-19:
This article makes observations about COVID-19 consumer behavior, demand shifts, shopping patterns, supply chain restructuring, market forces dynamics, and significant government engagement. The new report offers further information, analysis, projections, and estimates about the impact of COVID-19 on the markets.
Reasons to Buy the Report:
- The newly revised, 405+ page books provide an in-depth investigation of the COVID-19 virus and pandemic. You can gain knowledge on subjects like regional impact analysis, worldwide prediction, competitive landscape analysis, and size & share of regional markets by using industry data and expert interviews.
- The free sample contains details about the market size, key players, profitability analysis, SWOT analysis, historical and projected statistics, growth Porter’s Five Forces analysis, revenue forecasts, industry trends, and financial ratios. Along with evaluations from Absolute Market Insights for various countries and regions, the study also provides thorough analyses of the major variables influencing the market’s growth.
- The Sample Report provides readers with a competitive edge by providing more information on the important market players, such as their sales volume, company strategy, and revenue analysis.
Key Benefits of Global Pet Cancer Therapeutics Market 2019 2027 Report:
- The research on global Pet Cancer Therapeutics Market 2019 2027 trends include extensive investigations of the past and future.
- The Global Pet Cancer Therapeutics Market 2019 2027 Growth Research Report offers comprehensive data on the Market Introduction, Market Summary, Global Market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and National levels.
- Research on global Pet Cancer Therapeutics Market 2019 2027 trends helps with identifying business prospects.
Purchase This Premium Report at @
Purchase Link Pet Cancer Therapeutics Market 2019 2027.
Pet Cancer Therapeutics Market 2019 2027 Regional Insights
The report provides both, qualitative and quantitative research of global pet cancer therapeutics market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global diesel engine and gas engine market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
The study provides a thorough investigation of numerous factors, such as the expansion of the Pet Cancer Therapeutics Market 2019 2027 in significant geographic areas. North America, Europe, Asia-Pacific, and Latin America are the principal geographical areas that the study addresses.
Why the Pet Cancer Therapeutics Market 2019 2027 Report is Beneficial?
- The Pet Cancer Therapeutics Market 2019 2027 study was put together using a thorough and modern research approach.
- The research contains a considerable amount of data on the most current product and technology advancements in the Pet Cancer Therapeutics Market 2019 2027 and offers a comprehensive assessment of the market competition for the Pet Cancer Therapeutics Market 2019 2027
- The wide range of evaluations on how these upgrades may affect the further growth of Pet Cancer Therapeutics Market 2019 2027
- The research report for the Pet Cancer Therapeutics Market 2019 2027 study contains in-depth historical information and analysis.
- The Pet Cancer Therapeutics Market 2019 2027 report’s insights are easily understood and include graphical representations of the data in the form of bar graphs, statistics, pie charts, etc.
Pet Cancer Therapeutics Market 2019 2027 Segmentation:
Within the Pet Cancer Therapeutics Market 2019 2027 market, various groupings have been formed depending on the product kind and usage. The share and growth rate of each market segment are assessed. The experts have also investigated possible areas that can profit the producers in the upcoming years. The geography analysis provides accurate volume and value forecasts, assisting market participants in fully understanding the overall industry.
By Animal Type
- Dogs
- Cats
- Horses
- Others
By Cancer Type
- Mast Cell Cancer
- Lymphoma
- Melanoma
- Mammary
- Squamous Cell Cancer
- Others
By Route of Administration
- Oral
- Intravenous
- Others
By Therapy Type
- Chemotherapy
- Targeted Therapy
- Combination Therapy
- Immunotherapy
By Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Global Pet Cancer Therapeutics Market 2019 2027 by Region Pet Cancer Therapeutics Market 2019 2027
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- France
- Italy
- Spain
- UK
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia-Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Absolute Markets Insights
Absolute Markets Insights is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Absolute Markets Insights has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Customization of the Report:
The report can be customized as per client needs or requirements, our sales executives will be happy to understand your needs and provide you with the most suitable reports.
For any queries-:
Contact Us:
Shreyas Tanna
Absolute Markets Insights| www.absolutemarketsinsights.com
India: +91-74002-42424.
Email: sales@absolutemarketsinsights.com
LinkedIn | Twitter | Facebook
